Custom Publishing
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Featured News
DEA Announces New Rules for Telemedicine Prescriptions of Controlled Substances
Permanent Telemedicine Rules Build on COVID-Era Flexibilities The U.S. Drug Enforcement Administration (DEA) has finalized new rules to make temporary telemedicine flexibilities introduced during the COVID-19 public health emergency permanent. These rules govern how...
Acid-Reducing Drugs Linked to Higher Risk of Migraines and Severe Headaches
Proton Pump Inhibitors Increase Migraine Risk by 70% People using proton pump inhibitors (PPIs), such as omeprazole and esomeprazole, are 70% more likely to experience migraines or severe headaches than non-users, according to a study published in Neurology Clinical...
Never Miss An Issue
